Introduction
CordenPharma is a leading full‐service Contract Development and Manufacturing Organization (CDMO) specializing in active pharmaceutical ingredients (APIs), excipients, drug products (DP), and packaging. With around 3,000 employees worldwide, we help pharmaceutical and biotech companies manufacture medicines to improve people’s lives.
Our network, spanning Europe and the US, provides flexible and specialized solutions across six technology platforms: Peptides, Lipids & Carbohydrates, Injectables, Highly Potent & Oncology, Small Molecules, and Oligonucleotides. We strive for excellence in supporting this network and are committed to delivering the highest quality products for patient well‑being.
Our People Vision: We strive for excellence. We share our passion. Together, we make a difference in patients’ lives.
Head of Development (m/f/d) - Innovative Synthesis
Location: Liestal. Start: as soon as possible. Employment: Full‑time, Permanent.
Dual role – You lead the Development function in Liestal and are part of the Site Leadership Team, while also heading Development across the Innovative Synthesis Business Unit (Liestal, Chenôve, Bergamo).
What you can expect
The role
This is a dual role: you lead the Development function in Liestal (and are part of the Site Leadership Team) while also heading Development across the Innovative Synthesis Business Unit (Liestal, Chenôve, Bergamo).
Strategic
* Drive continuous improvement and state‑of‑the‑art process development and analytical methods, including phase‑appropriate standards.
* Define and implement internal development standards, tools, and process flows together with the process owner "Project Management".
* Build a culture of Operational Excellence & Continuous Improvement, ensuring learnings are systematically shared between Development and Manufacturing.
* Shape technology advancement by working closely with Innovation to introduce new technologies, equipment, and techniques.
* Own capital planning and ensure a state‑of‑the‑art DEV infrastructure (facilities, maintenance, investments for obsolescence, capacity, and technology).
* Contribute to operational strategy and long‑term development as a member of the Business Unit Leadership Team and Site Leadership Team Liestal.
* Support Commercial & Project Management in new business capture (opportunity assessment, project evaluations) and participate in customer visits when technical excellence is key.
Operational
* Provide disciplinary and technical leadership for Development teams across the Business Unit (with direct responsibility in Liestal and matrix leadership across sites).
* Manage budgets and cost centres for the function.
* Lead cross‑site resource management to optimise utilisation and scheduling in close cooperation with Project Management.
* Drive people management & development (recruitment, coaching, training, succession planning).
* Ensure SHE compliance and appropriate internal/external quality standards (ISO, GMP where applicable), including ownership of DEV quality documentation (guidelines, SOPs, templates).
Qualifications
* PhD preferred in Organic Chemistry, Chemical Engineering, or equivalent.
* 10+ years in the chemical‑pharmaceutical industry with a focus on process research & development, innovation and/or project management and manufacturing for Small Molecules, Lipids, and Peptides.
* Strong leadership capabilities.
* German & English proficiency.
What we offer
* Full coverage of KTG / NBU premiums – we cover 100% of the costs.
* Above‑average pension fund benefits – we cover 70% of the contributions.
* An attractive workplace with a high level of responsibility.
* Attractive and performance‑related compensation package.
Interested?
If you enjoy working in a team and are interested in a varied area of responsibility, with the ability to think and act beyond your own area, then this role might be for you.
CordenPharma does not accept unsolicited applications from recruitment agencies. Any resumes submitted without a prior agreement will not be considered and will not create any obligations for CordenPharma.
#J-18808-Ljbffr